TransCode Therapeutics, Inc. (RNAZ) Earnings History

Quarterly EPS Results — source: SEC EDGAR
QuarterEPS EstimateEPS ActualSurpriseResult
Q22026 FY2026—$-7.17—Miss
Q12026 FY2026—$-21.28—Miss
Q42025 FY2025—$-18.58—Miss

Back to RNAZ overview · RNAZ holders · RNAZ KPIs

Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.